Research Project
Grant-in-Aid for Challenging Research (Exploratory)
We have established a system to measure the ability of DNA homologous recombination repair using primary breast cancer cells directly grown from breast cancer tissues. The system uses fluorescence immunostaining for EdU, CENP-F, and 53BP1 after olaparib treatment and scores by the number of DNA double-strand breaks in the G2 phase before and after 24 h treatment. This system was validated using siRNA-based BRCA1 knockdown cells.Using the system, we selected five cases in which homologous recombination seemed to be impaired and performed whole genome sequencing. We did not identify any known mutations which have been suggested to be associated with hereditary beast cancers; however, we identified some alterations that fit the hereditary model. The functional analysis of these genes is necessary.
遺伝子変異解析では、病的意義が判明している既知の遺伝子変異を検出した場合のみDNA相同組み換え修復能欠損があるかどうか、ひいては特定の薬剤の適応となるかが分かるが、いまだ全ての変異が明らかにされているわけではない。しかし、実際に乳癌組織より細胞を培養し、本研究で開発した手法を用いれば、DNA相同組み換え修復能を予想でき、薬剤を選択できる可能性が示唆された。
All 2021 2020 2019 2018
All Journal Article (9 results) (of which Int'l Joint Research: 8 results, Peer Reviewed: 9 results, Open Access: 5 results) Presentation (11 results) (of which Int'l Joint Research: 1 results, Invited: 5 results)
Science Advances
Volume: 6 Issue: 51 Pages: 7197-7197
10.1126/sciadv.abd7197
Proceedings of the National Academy of Sciences
Volume: 117 Issue: 25 Pages: 14412-14420
10.1073/pnas.1920165117
Journal of Medical genetics
Volume: 57 Issue: 4 Pages: 245-253
10.1136/jmedgenet-2019-106213
Thyroid
Volume: 308 Issue: 9 Pages: 1-13
10.1089/thy.2020.0308
J Clin Endocrinol Metab
Volume: 105 Issue: 12 Pages: 573-573
10.1210/clinem/dgaa573
Cell
Volume: 19 Issue: 6 Pages: 1228-1244
10.1016/j.cell.2020.02.010
120006871293
Volume: 29 Issue: 8 Pages: 1105-1114
10.1089/thy.2018.0695
120006988431
Volume: in press Issue: 5 Pages: 674-682
10.1089/thy.2018.0212
Journal of Medical Genetics
Volume: 55 Issue: 5 Pages: 329-343
10.1136/jmedgenet-2017-104877